Rock Creek Pharmaceuticals Announces Presentation Of Four Anatabine Projects At Neuroscience 2014
October 23, 2014 at 09:08 AM EDT
Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic ...